title: Two for-Met-Leu-Phe-OMe analogues trigger selective neutrophil responses. A differential effect on cytosolic free Ca2+.
abstract: For-Thp-Leu-Ain-OMe and for-Met-delta(z)Leu-Phe-OMe are two conformationally restricted fMLP-OMe analogues able to discriminate between different biological responses of human neutrophils. In this paper, we demonstrate that the former peptide, which evokes only chemotaxis, does not alter human neutrophil Ca2+ levels. In contrast, for-Met-delta(z)Leu-Phe-OMe, which induces superoxide anion release and degranulation but not chemotaxis, significantly increases the cation concentration. The chelation of Ca2+ in both extracellular and intracellular media abolishes O2- production triggered by for-Met-delta(z)Leu-Phe-OMe, while the same procedure does not affect neutrophil chemotaxis towards for-Thp-Leu-Ain-OMe. We therefore suggest that chemotaxis, unlike superoxide anion release, is independent of Ca2+ enhancement in human neutrophils.
authors.affiliation: Dipartimento di Biologia, Università degli Studi, Ferrara, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Fabbri
authors.forename: S
authors.initials: S
authors.lastname: Spisani
authors.forename: C
authors.initials: C
authors.lastname: Biondi
authors.forename: L
authors.initials: L
authors.lastname: Barbin
authors.forename: M L
authors.initials: ML
authors.lastname: Colamussi
authors.forename: A
authors.initials: A
authors.lastname: Cariani
authors.forename: S
authors.initials: S
authors.lastname: Traniello
authors.forename: I
authors.initials: I
authors.lastname: Torrini
authors.forename: M E
authors.initials: ME
authors.lastname: Ferretti
mesh_terms: D002118:Calcium / Q000378:metabolism*; D002614:Chelating Agents / Q000494:pharmacology; D002634:Chemotaxis, Leukocyte; D003600:Cytosol / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004963:Estrenes / Q000494:pharmacology; D006801:Humans; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000031:analogs & derivatives* / Q000494:pharmacology; D009504:Neutrophils / Q000187:drug effects* / Q000378:metabolism; D011760:Pyrrolidinones / Q000494:pharmacology; D015290:Second Messenger Systems / Q000502:physiology*; D013481:Superoxides / Q000378:metabolism; D010738:Type C Phospholipases / Q000037:antagonists & inhibitors
chemical_list: D002614:Chelating Agents; D004791:Enzyme Inhibitors; D004963:Estrenes; D011760:Pyrrolidinones; C109944:formyl-Thp-leucyl-Ain-methyl ester; D013481:Superoxides; C060229:1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione; C080504:formyl-methionyl-delta(Z)-dehydroleucyl-phenylalanine methyl ester; D009240:N-Formylmethionine Leucyl-Phenylalanine; D010738:Type C Phospholipases; D002118:Calcium